Sabra Health Care REIT, Inc.
SBRA · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $190 | $189 | $184 | $182 |
| % Growth | 0.5% | 3.1% | 0.7% | – |
| Cost of Goods Sold | $70 | $61 | $60 | $60 |
| Gross Profit | $120 | $128 | $124 | $123 |
| % Margin | 63.3% | 67.7% | 67.3% | 67.2% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $13 | $13 | $13 | $13 |
| SG&A Expenses | $13 | $13 | $13 | $13 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $48 | $44 | $43 | $42 |
| Operating Expenses | $61 | $56 | $56 | $55 |
| Operating Income | $60 | $72 | $67 | $67 |
| % Margin | 31.3% | 38% | 36.7% | 36.9% |
| Other Income/Exp. Net | -$37 | -$6 | -$27 | -$20 |
| Pre-Tax Income | $23 | $66 | $41 | $47 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $23 | $66 | $40 | $47 |
| % Margin | 11.9% | 34.7% | 22% | 25.6% |
| EPS | 0.094 | 0.28 | 0.17 | 0.2 |
| % Growth | -66.4% | 64.7% | -15% | – |
| EPS Diluted | 0.093 | 0.27 | 0.17 | 0.19 |
| Weighted Avg Shares Out | 240 | 238 | 238 | 237 |
| Weighted Avg Shares Out Dil | 244 | 241 | 240 | 240 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $28 | $27 | $28 |
| Depreciation & Amortization | $49 | $44 | $43 | $42 |
| EBITDA | $100 | $137 | $111 | $125 |
| % Margin | 52.8% | 72.5% | 60.6% | 68.7% |